Treatment of breast cancer cells with the MYCMI-6, MYCMI-11 and MYCMI-14 for 24 hours significantly decreased MYC:MAX isPLA signals to 7%, 23% and 23% of DMSO-treated controls, respectively (Fig. 2B and C). This evidence concerns the gene MYC and breast carcinoma.